Oscar Health (NYSE:OSCR) Price Target Raised to $20.00 at Wells Fargo & Company

Oscar Health (NYSE:OSCR – Free Report) had its target price increased by Wells Fargo & Company from $12.00 to $20.00 in a report published on Thursday, Benzinga reports. Wells Fargo & Company currently has an overweight rating on the stock. OSCR has been the topic of several other reports. The Goldman Sachs Group lifted their […]

Related Keywords

United States ,Switzerland ,Swiss ,America ,Alessandreac Quane ,Richard Scott Blackley ,Insider Activity At Oscar Health ,Envestnet Asset Management Inc ,Oscar Health Company Profile ,Goldman Sachs Group ,Swiss National Bank ,Wells Fargo Company ,Charles Schwab Investment Management Inc ,Advisor Group Holdings Inc ,News Ratings For Oscar Health Daily ,Institutional Investors Weigh In On Oscar Health ,Oscar Health Inc ,Oscar Health Stock Down ,Analyst Recommendations For Oscar Health ,Oscar Health ,Free Report ,Wells Fargo ,Moderate Buy ,Health Stock Down ,Get Free Report ,Scott Blackley ,Asset Management ,Group Holdings ,National Bank ,Charles Schwab Investment Management ,Schwab Investment Management ,Oscar Health Daily ,Nyse Oscr ,Aoscr ,Finance ,Boost Price Target ,